• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Excess weight risk factor for alcoholic liver disease.

作者信息

Naveau S, Giraud V, Borotto E, Aubert A, Capron F, Chaput J C

机构信息

Service d'Hépato-Gastro-Enterologie, Hôpital Antoine Béclère, Clamart, France.

出版信息

Hepatology. 1997 Jan;25(1):108-11. doi: 10.1002/hep.510250120.

DOI:10.1002/hep.510250120
PMID:8985274
Abstract

Though the hepatotoxicity of ethanol has been established, only 8% to 20% of chronic alcoholics develop cirrhosis. The aim of this study was to assess whether being overweight is a risk factor for alcoholic liver disease. One thousand six hundred four alcoholic patients were studied. According to the liver biopsies, 194 patients had a normal liver; 402 had steatosis without fibrosis; 281 presented with fibrosis, with or without steatosis; 119 presented with acute alcoholic hepatitis (AAH) without cirrhosis; 232 indicated cirrhosis without AAH; and 179 presented with cirrhosis with AAH. One hundred ninety-seven patients had clinically obvious cirrhosis. In the study, five variables were studied as risk factors: age, sex, daily consumption of alcohol during the previous 5 years, the total duration of alcohol abuse, and tendency to be overweight (body mass index [BMI] > or = 25 in women and > or = 27 in men). The BMI was calculated according to the minimum weight over the 10 previous years. In the first stepwise logistic regression analysis, age, being overweight for at least 10 years, being of the female sex, and the total duration of alcohol abuse were independently correlated with the presence of cirrhosis. In the second analysis, female sex being overweight were the two independent risk factors of AAH. In the third analysis, being overweight for at least 10 years was the only independent risk factor of steatosis. These results show that the presence of excess weight for at least 10 years is a risk factor for cirrhosis, AAH, and steatosis. Our results suggest that there is a possible potential for the metabolic effects of ethanol ingestion caused by excess weight in patients with alcoholic liver disease.

摘要

相似文献

1
Excess weight risk factor for alcoholic liver disease.
Hepatology. 1997 Jan;25(1):108-11. doi: 10.1002/hep.510250120.
2
Risk factors of fibrosis in alcohol-induced liver disease.酒精性肝病中纤维化的危险因素。
Hepatology. 2002 Mar;35(3):635-8. doi: 10.1053/jhep.2002.31782.
3
[Predictive risk factors for progression to cirrhosis in early stage alcoholic liver disease].[早期酒精性肝病进展为肝硬化的预测风险因素]
Gastroenterol Clin Biol. 1998 Dec;22(12):997-1002.
4
Serum leptin in patients with alcoholic liver disease.酒精性肝病患者的血清瘦素
Alcohol Clin Exp Res. 2006 Aug;30(8):1422-8. doi: 10.1111/j.1530-0277.2006.00170.x.
5
Predictive factors for pure steatosis in alcoholic patients.酒精性肝病患者单纯性脂肪变性的预测因素
Alcohol Clin Exp Res. 2009 Jun;33(6):1104-10. doi: 10.1111/j.1530-0277.2009.00932.x. Epub 2009 Mar 23.
6
Long-term prognosis of patients with alcoholic liver cirrhosis: a 15-year follow-up study of 100 Norwegian patients admitted to one unit.酒精性肝硬化患者的长期预后:对收治于同一科室的100例挪威患者进行的15年随访研究
Scand J Gastroenterol. 2004 Sep;39(9):858-63. doi: 10.1080/00365520410006350.
7
Predictive factors for the severity of liver fibrosis in patients with chronic hepatitis C and moderate alcohol consumption.慢性丙型肝炎且有中度饮酒习惯患者肝纤维化严重程度的预测因素
Rom J Gastroenterol. 2003 Sep;12(3):183-7.
8
Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis.酒精性或病毒性丙型肝硬化患者肝细胞癌的危险因素。
Clin Gastroenterol Hepatol. 2006 Aug;4(8):1062-8. doi: 10.1016/j.cgh.2006.05.013. Epub 2006 Jul 14.
9
[Patients with alcoholic liver disease hospitalized in gastroenterology. A national multicenter study].[因酒精性肝病入住胃肠病科的患者。一项全国多中心研究]
Gastroenterol Clin Biol. 2001 Feb;25(2):131-6.
10
Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?肥胖是肝硬化患者肝细胞癌的独立危险因素吗?
Hepatology. 2002 Jul;36(1):150-5. doi: 10.1053/jhep.2002.33713.

引用本文的文献

1
Is There a Diagnostic Miracle on the Horizon? Emerging Biomarkers in MASLD.是否即将出现诊断奇迹?非酒精性脂肪性肝病中的新兴生物标志物。
J Clin Med. 2025 Aug 30;14(17):6148. doi: 10.3390/jcm14176148.
2
Assessment of metabolic dysfunction-associated fatty liver disease in primary care: a consensus statement summary.基层医疗中代谢功能障碍相关脂肪性肝病的评估:共识声明摘要
Med J Aust. 2025 Sep 1;223(5):268-276. doi: 10.5694/mja2.70008. Epub 2025 Jul 28.
3
Association between insulin and liver function tests, liver disease and cirrhosis in population-based cohorts with long term follow-up.
基于人群队列长期随访中胰岛素与肝功能检查、肝脏疾病及肝硬化之间的关联。
World J Hepatol. 2025 Jun 27;17(6):107160. doi: 10.4254/wjh.v17.i6.107160.
4
Liver transplantation for alcohol-associated liver disease: The changing landscape.酒精性肝病的肝移植:不断变化的形势。
Hepatol Forum. 2025 Mar 1;6(2):77-86. doi: 10.14744/hf.2024.2024.0057. eCollection 2025.
5
MetALD: Clinical aspects, pathophysiology and treatment.线粒体酒精性肝病:临床特征、病理生理学及治疗
JHEP Rep. 2024 Nov 2;7(2):101250. doi: 10.1016/j.jhepr.2024.101250. eCollection 2025 Feb.
6
Immunology and treatments of fatty liver disease.脂肪肝疾病的免疫学与治疗方法
Arch Toxicol. 2025 Jan;99(1):127-152. doi: 10.1007/s00204-024-03920-1. Epub 2024 Dec 18.
7
Disrupted balance between pro-inflammatory lipid mediators and anti-inflammatory specialized pro-resolving mediators is linked to hyperinflammation in patients with alcoholic hepatitis.促炎脂质介质与抗炎特异性促消退介质之间的平衡失调与酒精性肝炎患者的炎症反应过度有关。
Front Immunol. 2024 Nov 21;15:1377236. doi: 10.3389/fimmu.2024.1377236. eCollection 2024.
8
Alcohol-associated liver disease: Natural history, management and novel targeted therapies.酒精性肝病:自然史、管理与新型靶向治疗
Clin Mol Hepatol. 2025 Feb;31(Suppl):S112-S133. doi: 10.3350/cmh.2024.0709. Epub 2024 Oct 31.
9
Liver fibrosis screening increases alcohol abstinence.肝纤维化筛查可提高戒酒率。
JHEP Rep. 2024 Jul 2;6(10):101165. doi: 10.1016/j.jhepr.2024.101165. eCollection 2024 Oct.
10
Characteristics and long-term mortality of individuals with MASLD, MetALD, and ALD, and the utility of SAFE score.合并代谢相关脂肪性肝病、代谢相关酒精性肝病和酒精性肝病患者的特征及长期死亡率,以及SAFE评分的效用
JHEP Rep. 2024 Jun 3;6(10):101127. doi: 10.1016/j.jhepr.2024.101127. eCollection 2024 Oct.